This study tested the influence of pretreatment bacterial density on the eradication rate of Helicobacter pylori with triple therapy. One hundred and thirty two patients with endoscopically confirmed H pylori positive, duodenal ulcer or antral gastritis were treated with triple therapy (colloidal bismuth/metronidazole/amoxicillin) for two weeks. Pretreatment urease activity was assessed by the "4C-urea breath test (UBT) in all patients. The mean (SD) pretreatment UBT concentration was similar in patients with duodenal ulcers (318.4 (175.0)) and patients with antral gastritis (288.9 (165.5)). Rauws et al have shown that one of the advantages of the urea breath test in the diagnosis of H pylori infection is that it also gives a quantitative assessment of the bacterial density in the stomach and correlates well with the histological findings.'1 This correlation has been validated recently by several independent studies. 12-14
pyloni was achieved in 85 of 132 patients (64.4%), but was significantly different between patients with high, intermediate, or low pretreatment urease activity (37.5%, 69.5%, and 87.8% respectively).
The mean post-treatment UBT value of patients in whom eradication failed was in direct correlation with the pretreatment UBT values. In conclusion, bacterial density, as assessed by urease activity, is an important factor in predicting H pylori eradication. It is suggested that the pretreatment UBT has the potential to identify patients who require modification of the standard therapeutic regimen. (Gut 1995; 36: [845] [846] [847] Keywords: Helicobacter pylon, urea breath test.
Rauws et al have shown that one of the advantages of the urea breath test in the diagnosis of H pylori infection is that it also gives a quantitative assessment of the bacterial density in the stomach and correlates well with the histological findings.'1 This correlation has been validated recently by several independent studies. 12-14
The purpose of this study was to evaluate the eradication rate of triple therapy in our patient population, and to examine the effect of the pretreatment bacterial density assessed by the 14C-urea breath test (UBT), on the eradication rate with this regimen.
Methods
The study included patients referred to our gastroenterology service for upper gastrointestinal symptoms, who were found to have endoscopically verified duodenal ulcers or chronic antral gastritis. During Figure 1 shows the eradication rates in the three patient groups in relation to pretreatment urease activity. It can be seen that with identical treatment regimens, the eradication rate was significantly different between patients with low, intermediate, and high urease activity (87-8%, 69-5%, and 37.5% respectively, p<005). The findings of this study show a direct relation between the pretreatment UBT value and the eradication rate of H pylori. A high UBT value means high urease activity in the stomach. This can result either from high bacterial density or increased urease activity of an individual bacterial strain. Recent studies, however, have shown that urease activity as assessed by the UBT, correlates well with bacterial density as measured by microbiological methods.12-14 The UBT performed in our laboratory includes cold urea and a test meal, to further improve the correlation between the UBT value and total bacterial density. 18 We also found that the mean post-treatment UBT value in patients whose treatment failed was higher in patients with high pretreatment urease activity than in those with low urease activity (Fig 2) . As all patients received the same treatment for the same length of time, this correlation provides additional support for the importance of bacterial density as a factor in Hpylo?i eradication.
Surprisingly, little attention has been given to the bacterial density or load as a possible factor in the eradication rate of H pylon. One reason is that pretreatment UBTs have not been routinely performed in most of the studies. The diagnosis of H pylori infection has usually been based on microbiological or histological examinations, or both, of minute tissue samples. These are subject to sampling problems, which make their use in global assessment of bacterial density unpractical.
Two recent studies, however, have included pretreatment urea breath testing in their protocol. Peterson et al examined the efficacy of monotherapy with clarythromycin in H pylori infection.'9 They pointed out in their results that no correlation was found between the bacterial density and the eradication results. However, their small patient group (34 patients) and low eradication rate preclude reliable conclusions. In another study using triple therapy and pretreatment urea breath testing no reference to the effect of bacterial density on the eradication rate is provided.20 Yet, the authors suggest in their conclusions that regardless of pathogenicity, the overall load of the organism may be important in determining the clinical outcome.
In conclusion, we found that a high UBT value, representing increased bacterial density of H pylori is associated with a significant reduction in the eradication rate after treatment with conventional triple therapy. These results show that pretreatment bacterial density should be taken into consideration when comparing the efficacy of various treatment regimens for H pylori eradication. Moreover, we suggest that a pretreatment UBT is useful when considering the choice of a therapeutic regimen. Prolongation of the treatment or giving higher dose of the same regimen may improve the eradication rate in cases with high bacterial density or load. 
